AstraZeneca raises outlook on strong cancer drug sales

Quick Summary:

Anglo-Swedish drugmaker AstraZeneca on Thursday raised its sales and profit forecast for 2024 after beating analyst expectations for second-quarter revenue on strong demand for its cancer and rare disease medicines.

It had previously expected revenue and profit to increase by a low double-digit to low-teens percentage.

"In the year to date we have continued to make encouraging progress with several disruptive technologies ...all of which have the potential to drive our growth beyond 2030," CEO Soriot said.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: EconomyBusiness

Markets: Malaysia

Topics: OncologyGrowth /Business/ RevenueGrowth RareDiseases Corporate News CancerTherapies AstraZeneca

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-25 @ 15:59:00 (14 hours ago)

News Timezone: GMT +8:00

News Source URL: thestar.com.my

Language: English

Article Length: 427 words

Reading Time: 3 minutes read

Sentences: 17 lines

Sentence Length: 26 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © The Star

News ID: 21770219

View Article Analysis

About The Star

Main Topics: EconomyBusiness

Official Website: thestar.com.my

Update Frequency: 41 posts per day

Year Established: 1971

Headquarters: Malaysia

News Last Updated: 6 hours ago

Coverage Areas: Malaysia

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #22

Publisher Details

Frequently Asked Questions